Nachrichten zur Illumina Inc. Aktie

Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama

Global conference to focus on advancing the transformative impacts of genomic health SAN DIEGO, July 18, 2022 /PRNewswire/ -- Illumina,…

Illumina erhält als eines der ersten Unternehmen weltweit die Genehmigung für das wissenschaftsbasierte Netto-Null-Ziel

Illumina, Inc.: San Diego (ots/PRNewswire) - Die Science Based Targets-Initiative hat die Ziele von Illumina bestätigt, bis 2050 Netto-Null-Treibhausgasemissionen zu…

Illumina erhält als eines der ersten Unternehmen weltweit die Genehmigung für das wissenschaftsbasierte Netto-Null-Ziel

Die Science Based Targets-Initiative hat die Ziele von Illumina bestätigt, bis 2050 Netto-Null-Treibhausgasemissionen zu erreichen SAN DIEGO, 14. Juli 2022…

Why Illumina Stock Is Tumbling This Week

Investors didnt like an unfavorable EU court decision....…

Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022

SAN DIEGO, July 14, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the second…

Form 8-K ILLUMINA, INC. For: Jul 14

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is the Options Market Predicting a Spike in Illumina (ILMN) Stock?

Investors need to pay close attention to Illumina (ILMN) stock based on the movements in the options market lately....…

Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

The Science Based Targets initiative has validated Illuminas targets to reach Net-Zero greenhouse gas emissions by 2050 SAN DIEGO, July…

Illumina loses EU antitrust probe challenge over Grail acquisition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

EU-Gericht: Kartellprüfung von Illumina-Grail-Deal ist rechtens

Von Kim Mackrael BRÜSSEL (Dow Jones)--Die Entscheidung der EU-Wettbewerbsbehörde, die milliardenschwere Übernahme des Testentwicklers Grail durch das US-Unternehmen Illumina…

UPDATE 1-Illumina loses challenge against EU antitrust probe into Grail deal

... (Reuters) - U.S. life sciences company Illumina on Wednesday lost its......…

EU regulators can examine Illumina, Grail deal, EU court says

...LUXEMBOURG (Reuters) - EU antitrust regulators can scrutinise U.S......…

Illumina to appeal EU court ruling on Grail deal

...LUXEMBOURG, July 13 (Reuters) - U.S. life sciences company Illumina......…

Where Illumina Stands With Analysts

Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: Latest Ratings for ILMN DateFirmActionFromTo…

Insiderhandel: SVP, Chief Technology Officer verkauft Aktien von Illumina im Wert von 107.800$

Aravanis, Alexander - Vorstand - Tag der Transaktion: 2022-07-07...…

Illumina investiert in einen 30-Millionen-Pfund-Venture-Fonds, um bahnbrechende Entwicklungen im Bereich der menschlichen Gesundheit voranzutreiben

Illumina, Inc.: San Diego (ots/PRNewswire) - Investitionen von LifeArc, Illumina und Illumina Ventures finanzieren Genomik-Startups für Absolventen des Illumina Accelerator…

Single Cell Analysis in Next-Generation Sequencing Market Research Report 2022 Featuring 10X Genomics, Bio-Rad, Dolomite Bio, Fluidigm, Illumina, Mission Bio, Qiagen, & Takara Bio

DUBLIN, June 30, 2022 /PRNewswire/ -- The "Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts,…

Illumina investiert in einen 30-Millionen-Pfund-Venture-Fonds, um bahnbrechende Entwicklungen im Bereich der menschlichen Gesundheit voranzutreiben

Investitionen von LifeArc, Illumina und Illumina Ventures finanzieren Genomik-Startups für Absolventen des Illumina Accelerator Cambridge SAN DIEGO, 30. Juni 2022…

Global Histology and Cytology IVD Market Report 2021-2022 & 2026 with Competitive Analysis of Agilent, Danaher, Hologic, Illumina, & Roche

DUBLIN, June 30, 2022 /PRNewswire/ -- The "Histology and Cytology IVD Market Update" report has been added to ResearchAndMarkets.coms offering.…

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates SAN DIEGO, June 28,…

Illumina (ILMN) Gains But Lags Market: What You Should Know

Illumina (ILMN) closed the most recent trading day at $193.93, moving +0.2% from the previous trading session....…

Illumina launches research only cancer genomic test co-developed with Merck

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

IN BRIEF: Illumina and Merck launch new tumour genome test

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina bringt gemeinsam mit Merck entwickelten Forschungstest auf den Markt, um tiefere Einblicke in das Tumorgenom zu gewinnen

Illumina, Inc.: San Diego (ots/PRNewswire) - Neuer Assay nutzt validierte HRD-Technologie von Myriad Genetics in Kombination mit Illumina TruSight™ Oncology…

Illumina bringt gemeinsam mit Merck entwickelten Forschungstest auf den Markt, um tiefere Einblicke in das Tumorgenom zu gewinnen

Neuer Assay nutzt validierte HRD-Technologie von Myriad Genetics in Kombination mit Illumina TruSight™ Oncology 500, einem einzigen, umfassenden Pan-Krebs-Test zur…

Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

New assay brings validated HRD technology from Myriad Genetics to the Illumina TruSight™ Oncology 500, a single, comprehensive pan-cancer test…

Insiderhandel: SVP, Chief Commercial Officer verkauft Aktien von Illumina im Wert von 53.713$

Tousi, Susan H. - Vorstand - Tag der Transaktion: 2022-06-10...…

Illumina Will Be Fine Despite Recent Concerns, Says CEO

The news that the company's CFO is leaving has spooked investors. The stock has tumbled 15.7% since Thursday morning....…

Illumina Loses Its CFO. Why the Stock Doesnt Need Any More Surprises.

Sam Samad will leave the company as chief financial officer on July 8 and will join Quest Diagnostics on July…

Why Illumina Stock Is Sinking Today

The genomic-sequencing companys CFO is unexpectedly leaving for another company....…

Illumina Shares Drop 10% After CFO Departure

Illumina Shares Drop 10% After CFO Departure...…

Quest Diagnostics Names Sam Samad CFO, Will Join In July From Illumina

Quest Diagnostics Names Sam Samad CFO, Will Join In July From Illumina...…

IN BRIEF: Illumina makes Joydeep Goswami interim CFO

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Says CFO Sam Samad to Depart July 8

Illumina Says CFO Sam Samad to Depart July 8...…

Quest Diagnostics hires former Illumina exec Samad as CFO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ILLUMINA, INC. For: Jun 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina names Joydeep Goswami as interim CFO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

JOYDEEP GOSWAMI APPOINTED INTERIM CFO; SAM SAMAD TO DEPART ILLUMINA

SAN DIEGO, June 9, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina Fights FTC to Keep Its Grail Deal Intact

Um den gesamten Artikel unter bloomberg.com zu lesen, klicken Sie bitte auf die Überschrift...…

Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions

SAN DIEGO, June 7, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO

SAN DIEGO, June 2, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…

Illumina (ILMN) to Offer Companion Diagnostic for VITRAKVI

Illuminas (ILMN) first companion diagnostic claim for TSO Comprehensive (EU) will help identify cancer patients with NTRK gene fusions for…

EU court to rule July 13 on Illumina challenge of EU review of Grail -sources

...By Foo Yun Chee BRUSSELS (Reuters) - A European court will decide......…

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy

First companion diagnostic claim for Illuminas TruSight™ Oncology Comprehensive (EU) test enables targeted therapy with Bayers VITRAKVI® (larotrectinib) for patients…